Charles W Goss

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Top Venues

PLoS neglected tropical diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Abby L Cheng, Patricia W Stone, Melissa A Armbrecht, Joanna Abraham, Ryan P Calfee, Charles W Goss
Behavioral Mechanisms That Mediate Mental and Physical Health Improvements in People With Chronic Pain Who Receive a Digital Health Intervention: Prospective Cohort Pilot Study. JMIR formative research 7 (2023)
Abhaya P Trivedi, Chase Hall, Charles W Goss, Daphne Lew, James G Krings, Mary Clare McGregor, Maanasi Samant, Jered P Sieren, Huashi Li, Ken B Schechtman, Joshua Schirm, Stephen McEleney, Sam Peterson, Wendy C Moore, Eugene R Bleecker, Deborah A Meyers, Elliot Israel, George R Washko, Bruce David Levy, Joseph K Leader, Sally E Wenzel, John V Fahy, Mark L Schiebler, Sean B Fain, Nizar N Jarjour, David T Mauger, Joseph M Reinhardt, John D Newell, Eirc A Hoffman, Mario Castro, Ajay Sheshadri, null null
Quantitative CT Characteristics of Cluster Phenotypes in the Severe Asthma Research Program Cohorts. Radiology 304 (2) (2022)
Livingstone Tavul, Moses Laman, Cade Howard, Bethuel Kotty, Anna Samuel, Catherine Bjerum, Kobie O'Brian, Steven Kumai, Matthew Amuga, Lina Lorry, Zebedee Kerry, Melvin Kualawi, Stephan Karl, Leo Makita, Lucy N John, Sibauk Bieb, James Wangi, Gary J Weil, Charles W Goss, Daniel J Tisch, William Pomat, Christopher L King, Leanne J Robinson
Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial. PLoS neglected tropical diseases 16 (2) (2022)
Josh G Kim, Ai Zhang, Adriana M Rauseo, Charles W Goss, Philip A Mudd, Jane A O'Halloran, Leyao Wang
The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma. Allergy 77 (12) (2022)
Alison Krentel, Nandha Basker, Madsen Beau de Rochars, Joshua Bogus, Daniel Dilliott, Abdel N Direny, Christine Dubray, Peter U Fischer, Adriani Lomi Ga, Charles W Goss, Myra Hardy, Cade Howard, Purushothaman Jambulingam, Christopher L King, Moses Laman, Jean Frantz Lemoine, Shruti Mallya, Leanne J Robinson, Josaia Samuela, Ken B Schechtman, Andrew C Steer, Taniawati Supali, Livingstone Tavul, Gary J Weil
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis. PLoS neglected tropical diseases 15 (3) (2021)
Christine L Dubray, Anita D Sircar, Valery Madsen Beau de Rochars, Joshua Bogus, Abdel N Direny, Jean Romuald Ernest, Carl R Fayette, Charles W Goss, Marisa A Hast, Kobie O'Brian, Guy Emmanuel Pavilus, Daniel Frantz Sabin, Ryan E Wiegand, Gary J Weil, Jean Frantz Lemoine
Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study. PLoS neglected tropical diseases 14 (6) (2020)
Charles W Goss, Katiuscia O'Brian, Christine Dubray, Peter U Fischer, Myra Hardy, Purushothaman Jambulingam, Christopher L King, Moses Laman, Jean Frantz Lemoine, Leanne J Robinson, Josaia Samuela, Swaminathan Subramanian, Taniawati Supali, Gary J Weil, Kenneth B Schechtman
Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach. PLoS neglected tropical diseases 13 (7) (2019)
Gary J Weil, Joshua Bogus, Michael Christian, Christine Dubray, Yenny Djuardi, Peter U Fischer, Charles W Goss, Myra Hardy, Purushothaman Jambulingam, Christopher L King, Vijesh Sridhar Kuttiat, Kaliannagounder Krishnamoorthy, Moses Laman, Jean Frantz Lemoine, Katiuscia K O'Brian, Leanne J Robinson, Josaia Samuela, Kenneth B Schechtman, Anita Sircar, Adinarayanan Srividya, Andrew C Steer, Taniawati Supali, Swaminathan Subramanian, null null
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study. PLoS medicine 16 (6) (2019)